Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma.
Brans B, Van Laere K, Gemmel F, Defreyne L, Vanlangenhove P, Troisi R, Van Vlierberghe H, Colle I, De Hemptinne B, Dierckx RA. Brans B, et al. Among authors: van laere k, van vlierberghe h. Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):928-32. doi: 10.1007/s00259-002-0791-8. Epub 2002 Apr 16. Eur J Nucl Med Mol Imaging. 2002. PMID: 12111134 Clinical Trial.
Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative (131)I-lipiodol therapy.
Brans B, Lambert B, De Beule E, De Winter F, Van Belle S, Van Vlierberghe H, de Hemptinne B, Dierckx RA. Brans B, et al. Among authors: van belle s, van vlierberghe h. Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1374-9. doi: 10.1007/s00259-002-0918-y. Epub 2002 Aug 6. Eur J Nucl Med Mol Imaging. 2002. PMID: 12271421 Clinical Trial.
Radionuclide detection of peritoneovenous shunt patency.
Gemmel F, Ravier M, Troisi R, Van Vlierberghe H, Lambert B, Renard V, Dierckx RA. Gemmel F, et al. Among authors: van vlierberghe h. Clin Nucl Med. 2003 Dec;28(12):986-7. doi: 10.1097/01.rlu.0000099811.48896.63. Clin Nucl Med. 2003. PMID: 14663324 No abstract available.
Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explant livers and clinical outcome.
Lambert B, Praet M, Vanlangenhove P, Troisi R, de Hemptinne B, Gemmel F, Van Vlierberghe H, Van de Wiele C. Lambert B, et al. Among authors: van vlierberghe h, van de wiele c. Cancer Biother Radiopharm. 2005 Apr;20(2):209-14. doi: 10.1089/cbr.2005.20.209. Cancer Biother Radiopharm. 2005. PMID: 15869457
(188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
Lambert B, Bacher K, Defreyne L, Van Vlierberghe H, Jeong JM, Wang RF, van Meerbeeck J, Smeets P, Troisi R, Thierens H, De Vos F, Van de Wiele C. Lambert B, et al. Among authors: van meerbeeck j, van vlierberghe h, van de wiele c. Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):344-52. doi: 10.1007/s00259-005-1954-1. Epub 2005 Dec 7. Eur J Nucl Med Mol Imaging. 2006. PMID: 16333675 Clinical Trial.
342 results